Oxitec’s technology for combatting dengue fever by releasing sterile mosquitoes into the wild will be applied to other insect-borne diseases by new owner Intrexon
The first paper describing this now world-leading class of therapeutics was published in August 1985. Since then, the UK Medical Research Council has received more than £580M in royalties
While it has a high reputation for the quality of its basic medical research, Poland lacks the means to translate this into the clinic. International collaboration is needed to help build this infrastructure
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.